ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PRMT5 up-regulation improves myocardial hypertrophy by mediating E2F-1/NF-KB/NLRP3 pathway

Zhang, Limin; Wang, Huihui; Li, Weimin*哈尔滨医科大学; 1
Preventive Medicine2023-7DOI: 10.1016/j.ypmed.2023.107553
1被引13阅读
引用收藏
分享

摘要

Various protein arginine methyltransferases (PRMTs) have been demonstrated to be aberrantly expressed in cardiovascular disease. This study aimed to investigate the role of PRMT5 in myocardial hypertrophy. Levels of fibrosis markers, NLRP3-ASC-Caspase1, inflammatory factors, myocardial hypertrophy markers and oxidative stress markers were determined in cardiomyocytes. Overexpression or knockdown models of PRMT5 and E2F-1 were constructed, and pharmacological intervention with NF -KB was determine the function of the PRMT5/E2F-1/NF-KB pathway in myocardial hypertrophy. Results shows that PRMT5 was down-regulated in the TAC rat model as well as in an in-vitro model of Ang II-induced myocardial hypertrophy. Overexpression of PRMT5 dramatically reduced Ang II-induced myocardial hypertrophy, fibrosis, inflammatory response, and oxidative stress, whereas knockdown of PRMT5 had the opposite effect. PRMT5 overexpression restrained E2F-1 expres-sion and impaired NF -KB phosphorylation and NLRP3-ASC-Caspase1 inflammasome activation. Mechanistically, PRMT5 knockdown contributed to E2F-1 expression, but E2F-1 knockdown or NF -KB inhibition reversed PRMT5 knockdown-mediated myocardial hypertrophy. PRMT5 attenuated NLRP3 inflammasome activation and ame-liorates angiotensin II-induced myocardial hypertrophy by regulating the E2F-1/NF-KB pathway.

学科与关键词

关键词
PRMT5E2F-1Myocardial hypertrophyInflammatory responseOxidative stress
相关
加载中…
  • miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway
    Cai, Sidong; Chang, Junlei; Su, Mengqi; Wei, Yinxia; Sun, Haoran; Chen, Cong*; Yiu, Kai-Hang*Cellular and Molecular Life Sciences, 2023, 80(12): 359.
  • NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
    Guo, Ningning; Zheng, Di; Sun, Jiaxin; Lv, Jian; Wang, Shun; Fang, Yu; Zhao, Zhenyi; Zeng, Sai; Guo, Qiuxiao; Tong, Jingjing*; Wang, Zhihua*Frontiers in Cardiovascular Medicine, 2021, 8: 791501.被引 4
  • PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1
    Geng Biao; Cai Yi; Gao Si; Lu Jing; Zhang Lu; Zou Jian; Liu Min; Yu Shanshan; Ye Jiantao*; Liu PeiqingBiochemical and Biophysical Research Communications, 2013, 430(3): 944-950.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Preventive Medicine
发表日期
2023-07
卷期
第 172 卷
页码
107553
DOI
10.1016/j.ypmed.2023.107553
语言
ENGLISH
成果收录
SCIE

作者

  • Z

    Zhang, Limin (第一作者)

    1 · harbin med univ

  • W

    Wang, Huihui

查看全部 3 位作者收起作者
  • L

    Li, Weimin (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417